Addex Historical Balance Sheet
| ADXN Stock | USD 5.55 0.16 2.80% |
Trend analysis of Addex Therapeutics balance sheet accounts such as Current Assets of 8 M, Assets Non Current of 475.7 K or Cash and Equivalents of 7.1 M provides information on Addex Therapeutics' total assets, liabilities, and equity, which is the actual value of Addex Therapeutics to its prevalent stockholders. By breaking down trends over time using Addex Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Addex Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Addex Therapeutics is a good buy for the upcoming year.
Addex |
About Addex Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Addex Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Addex Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Addex Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Addex currently owns. An asset can also be divided into two categories, current and non-current.
Addex Therapeutics Balance Sheet Chart
Addex Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Addex Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Addex Therapeutics' Deferred Revenue is very stable as compared to the past year. . As of the 30th of November 2023, Shareholders Equity Attributable to Parent is likely to grow to about 5 M, while Debt Current is likely to drop about 282.7 K. Add Fundamental
Total Assets
Total assets refers to the total amount of Addex Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Addex Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; [Intangibles]; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.Current Assets
Current assets of Addex Therapeutics include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Addex Therapeutics. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.Shareholders Equity Attributable to Parent
A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.Total Liabilities
Deferred Income Tax is recorded on Addex Therapeutics balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Addex Therapeutics books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.Most accounts from Addex Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Addex Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in commodities. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.At this time, Addex Therapeutics' Deferred Revenue is very stable as compared to the past year. . As of the 30th of November 2023, Shareholders Equity Attributable to Parent is likely to grow to about 5 M, while Debt Current is likely to drop about 282.7 K.
| 2020 | 2021 | 2022 | 2023 (projected) | Current Assets | 19.5M | 21.9M | 7.8M | 8.0M | Total Assets | 20.2M | 22.5M | 8.3M | 8.5M |
Addex Therapeutics balance sheet Correlations
Click cells to compare fundamentals
Addex Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Addex Therapeutics balance sheet Accounts
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 (projected) | ||
| Total Assets | 42.2M | 33.0M | 20.2M | 22.5M | 8.3M | 8.5M | |
| Current Assets | 42.2M | 32.4M | 19.5M | 21.9M | 7.8M | 8.0M | |
| Assets Non Current | 63.3K | 639.9K | 692.2K | 600.0K | 453.1K | 475.7K | |
| Cash and Equivalents | 41.7M | 31.5M | 18.7M | 20.5M | 7.0M | 7.1M | |
| Cash and Equivalents USD | 42.5M | 32.5M | 21.2M | 22.5M | 7.5M | 7.7M | |
| Shareholders Equity Attributable to Parent | 39.2M | 25.5M | 14.6M | 16.9M | 4.9M | 5.0M | |
| Shareholders Equity USD | 40.0M | 26.3M | 16.6M | 18.6M | 5.3M | 5.4M | |
| Investments | 62.4K | 82.9K | 124.1K | 75.1K | 57.5K | 70.8K | |
| Investments Current | 8.0K | 14.0K | 64.9K | 17.1K | 3.2K | 3.2K | |
| Investments Non Current | 54.4K | 68.9K | 59.1K | 57.9K | 54.4K | 57.7K | |
| Total Liabilities | 3.0M | 7.5M | 5.6M | 5.6M | 3.4M | 4.4M | |
| Current Liabilities | 2.3M | 5.7M | 3.6M | 4.1M | 3.3M | 3.7M | |
| Liabilities Non Current | 639.4K | 1.8M | 2.0M | 1.5M | 87.0K | 89.3K | |
| Trade and Non Trade Payables | 2.1M | 4.2M | 2.5M | 3.8M | 3.0M | 3.2M | |
| Property Plant and Equipment Net | 8.9K | 571.0K | 633.1K | 542.1K | 398.7K | 417.9K | |
| Trade and Non Trade Receivables | 273.0K | 118.0K | 68.4K | 164.8K | 416.9K | 349.2K | |
| Accumulated Retained Earnings Deficit | (286.1M) | (300.8M) | (313.7M) | (329.1M) | (349.9M) | (377.5M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Addex Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Addex Therapeutics' short interest history, or implied volatility extrapolated from Addex Therapeutics options trading.
Pair Trading with Addex Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Addex Stock
| + | 0.82 | JNJ | Johnson Johnson | Aggressive Push | PairCorr | |
| + | 0.75 | MRK | Merck Company | Fiscal Quarter End 31st of December 2023 | PairCorr | |
| + | 0.89 | PFE | Pfizer Inc | Fiscal Quarter End 31st of December 2023 | PairCorr |
Moving against Addex Stock
| - | 0.71 | METROPOLIS | Metropolis Healthcare | PairCorr | ||
| - | 0.6 | MSFT | Microsoft | Fiscal Quarter End 31st of December 2023 | PairCorr |
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in commodities. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Addex Stock analysis
When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (20.52) | Revenue Per Share 3.72 | Quarterly Revenue Growth (0.21) | Return On Assets (0.77) | Return On Equity (1.98) |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.